Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05378347 · ClinicalTrials.gov registry record · NA
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
A NA study of Abdominal Aortic Aneurysm and Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), sponsored by Medtronic Cardiovascular.
- Recruiting
- Registry status
- NA
- Development phase
- 550
- Enrollment target
- 20
- Study locations
NCT05378347 is a NA study of Abdominal Aortic Aneurysm and Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder) that is actively recruiting participants, run by Medtronic Cardiovascular. The registered enrollment target is 550 participants, above the 419-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (31% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT05378347, a NA study of Abdominal Aortic Aneurysm and Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), is actively recruiting participants, sponsored by Medtronic Cardiovascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.
Conditions Studied
Interventions
- DEVICE Medtronic Endurant II or Endurant IIs Stent Graft System
- DEVICE Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis
Study Locations (20)
California
- Loma Linda University Medical Center - Loma Linda
- Hoag Hospital - Newport Beach
- University of California Irvine Medical Center - Orange
- University of California Davis Medical Center - Sacramento
- University of California San Francisco UCSF Medical Center - San Francisco
Florida
- Mayo Clinic Jacksonville - Jacksonville
- Sarasota Memorial Hospital - Sarasota
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Baystate Medical Center - Springfield
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
- Mayo Clinic Rochester - Rochester
Colorado
- Denver Health Medical Center - Denver
Connecticut
- Yale Center for Clinical Investigation - New Haven
District of Columbia
- Medstar Washington Hospital Center - Washington D.C.
Georgia
- Northside Hospital Forsyth - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2023-01-05 |
| Est. Completion | 2031-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05378347
The ClinicalTrials.gov registry entry for NCT05378347 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 419-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (31% higher). The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which Medtronic Endurant II or Endurant IIs Stent Graft System is the first listed.
NCT05378347 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05378347 about?
NCT05378347 is a clinical study titled "Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial". The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follo...
What is the current status of trial NCT05378347?
This trial is currently recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2023-01-05. Estimated completion is 2031-05.
What conditions does trial NCT05378347 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder).
What interventions are being tested in trial NCT05378347?
The interventions under investigation include: Medtronic Endurant II or Endurant IIs Stent Graft System (DEVICE), Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT05378347?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05378347 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
ACTIVE NOT RECRUITING · NA
-
Post-Approval Study of the TREO Abdominal Stent-Graft System
ACTIVE NOT RECRUITING · NA
-
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
COMPLETED · NA
-
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair
COMPLETED · NA
Explore more on PlainTrial
Abdominal Aortic Aneurysm
All registered trials for this condition
Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.